I think we need to do much more than simply gain orphan status for 50c though - already at $300M+ and there's quite a few penny stocks on the ASX with Orphan Drug Designation that have done nothing in terms of adding value on the back of it. It's all about what you do with it i guess.
- Forums
- ASX - By Stock
- PYC
- Ann: Shareholder Update - Forward View 2020 Milestones
Ann: Shareholder Update - Forward View 2020 Milestones, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
0.001(1.04%) |
Mkt cap ! $452.6M |
Open | High | Low | Value | Volume |
9.6¢ | 9.7¢ | 9.4¢ | $264.4K | 2.765M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 59037 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 49995 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 59037 | 0.094 |
1 | 90791 | 0.093 |
2 | 75000 | 0.092 |
3 | 107875 | 0.091 |
7 | 193499 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 49995 | 1 |
0.098 | 50000 | 1 |
0.105 | 452043 | 3 |
0.110 | 802229 | 7 |
0.115 | 585111 | 3 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
PYC (ASX) Chart |